Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Total Current Liabilities (2020 - 2026)

Cytek Biosciences filings provide 6 years of Total Current Liabilities readings, the most recent being $77.8 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 14.99% to $77.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $77.8 million, a 14.99% increase, with the full-year FY2025 number at $77.8 million, up 14.99% from a year prior.
  • Total Current Liabilities hit $77.8 million in Q4 2025 for Cytek Biosciences, up from $75.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $77.8 million in Q4 2025 to a low of $28.2 million in Q2 2021.
  • Median Total Current Liabilities over the past 5 years was $55.6 million (2024), compared with a mean of $53.9 million.
  • Biggest five-year swings in Total Current Liabilities: surged 50.36% in 2022 and later decreased 2.26% in 2024.
  • Cytek Biosciences' Total Current Liabilities stood at $33.2 million in 2021, then surged by 47.8% to $49.0 million in 2022, then increased by 14.65% to $56.2 million in 2023, then increased by 20.34% to $67.7 million in 2024, then increased by 14.99% to $77.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $77.8 million (Q4 2025), $75.2 million (Q3 2025), and $73.3 million (Q2 2025) per Business Quant data.